Gene: ZNF23
Official Full Name: zinc finger protein 23provided by HGNC
Gene Summary: Enables sequence-specific double-stranded DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO34736 | ZNF23 Knockout cell line (HeLa) | Human | ZNF23 | 1:3~1:6 | Negative | Online Inquiry |
KO34737 | ZNF23 Knockout cell line (HCT 116) | Human | ZNF23 | 1:2~1:4 | Negative | Online Inquiry |
KO34738 | ZNF23 Knockout cell line (HEK293) | Human | ZNF23 | 1:3~1:6 | Negative | Online Inquiry |
KO34739 | ZNF23 Knockout cell line (A549) | Human | ZNF23 | 1:3~1:4 | Negative | Online Inquiry |
ZNF23 Gene Knockout Cell Lines are specially engineered cellular models designed to facilitate the investigation of the ZNF23 gene's function and its implications in various biological processes. By employing state-of-the-art CRISPR-Cas9 gene-editing technology, these cell lines have been precisely modified to disrupt the ZNF23 gene, allowing researchers to study the resulting phenotypic and molecular changes directly linked to its loss of function.
The key function of the ZNF23 Gene Knockout Cell Lines lies in their ability to mimic pathological conditions where ZNF23 is downregulated or absent. The mechanism of action enables researchers to observe alterations in gene expression profiles, protein interactions, and cellular pathways, thereby providing insights into ZNF23’s role in critical processes such as cell cycle regulation, differentiation, and tumorigenesis. These alterations can reveal potential therapeutic targets for a range of diseases, including cancers and genetic disorders.
From a scientific perspective, these cell lines are invaluable in both research and clinical applications. They serve as essential tools for drug discovery, functional genomics, and toxicity testing, allowing for the high-throughput screening of therapeutic compounds aimed at modulating the functions associated with ZNF23. The insights gathered can facilitate the development of novel interventions and enhance the understanding of gene-gene interactions in complex biological systems.
The ZNF23 Gene Knockout Cell Lines stand out due to their rigorously validated knockout efficiency, reproducibility, and consistency in experimental outcomes. Compared to other models, these cell lines minimize experimental variability, providing a reliable platform for hypothesis testing. Furthermore, their compatibility with widely used assays enhances their utility in diverse applications.
For researchers and clinicians aiming to elucidate gene functions or identify pathways influenced by ZNF23, these knockout cell lines present an unparalleled opportunity to advance scientific knowledge and potentially translate findings into clinical practice. Our company specializes in the production of high-quality biological research tools, ensuring that our customers receive products that support innovative research and contribute to breakthroughs in their respective fields.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.